FRNM

At a glance

Freenome, Inc. (FRNM) is listed on NASDAQ and classified in Diagnostics & Research, part of the Healthcare sector. It is headquartered in Brisbane, United States and has 375 employees. The company is worth $1.26B. Revenue was $30.41M in fiscal 2025, up 955.1% from the year before. It reported a net loss of $219.34M. The share price is 32.9% below its 52-week high of $17.50. None of the 38 superinvestors we track reported it in their latest 13F. No open-market insider trades in it were filed over the last 30 days.

Written from the data on this page: SEC filings (13F, Form 4, annual reports) and market prices.

Key metrics

Market cap

$1.26B

P/E

—

Forward P/E

—

P/B

—

Dividend yield

0.00%

Payout

—

EPS

-$2.04

ROE

—

Profit margin

0.00%

Revenue growth

+106.50%

Beta

0.45

52-week high

$17.50

52-week low

$9.95

History

Year by year, from the annual reports; dividends from the payments themselves.

Investors holding this

Major managers that reported this stock in their latest 13F.

None of the investors we track reported a position in FRNM.

Indicators, year by year

The last 2 closed years, each at that year’s closing price and reported numbers.

Median of the years shown; P/E years above 200x are left out.

Others in the same sector

Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.

About the company